Biomarkers for Oncology
JH · Effective Oct 1, 2015
47 active Medicare policies list 81450, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J6 · Effective Aug 1, 2018
JK · Effective Aug 1, 2018
9 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 81450 |
|---|---|---|
| Genetic Testing for Hematologic Malignancies and Suspected Myeloid Disorders | Sep 1, 2026 | Covered |
| Genomic and Molecular Biomarker Testing for Cancer | Sep 23, 2026 | Covered |
| Policy | Effective | Status of 81450 |
|---|---|---|
| Tumor Markers | Mar 5, 2024 | Covered |
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J9 · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
J6 · Effective Apr 1, 2026
National · Effective Apr 24, 2025
National · Effective Feb 5, 2026
National · Effective Apr 24, 2025
J5 · Effective Apr 24, 2025
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
National · Effective Oct 1, 2026
National · Effective Sep 24, 2026
J5 · Effective Oct 1, 2026
National · Effective Oct 1, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
| Policy | Effective | Status of 81450 |
|---|
| Concert Genetic Testing Oncology: Hematologic Malignancy | Not recorded | Referenced |
|---|
| Policy | Effective | Status of 81450 |
|---|---|---|
| Cigna Comprehensive Code List | Mar 7, 2026 | Prior auth required |
| Policy | Effective | Status of 81450 |
|---|---|---|
| Genetic Testing for Myeloid Neoplasms and Leukemia | Jun 1, 2026 | Covered |
| Policy | Effective | Status of 81450 |
|---|---|---|
| Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions | Aug 1, 2026 | Covered |
| Policy | Effective | Status of 81450 |
|---|---|---|
| Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions | Aug 1, 2026 | Covered |
| Policy | Effective | Status of 81450 |
|---|---|---|
| Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions | Aug 1, 2026 | Covered |